Provenge Works! What The Heck Is The FDA Waiting For?
April 6th, 2010 | Posted by CTLDear FDA,
As you read this on your next visit here, why not just agree to meet with us in person.
Are you aware Ms. Midthun refused our request to meet with her?
Here is her reply:
http://caretolive.com/2010-01-11/cber-responds-to-letter-from-caretolive/
If you are interested in how we feel and what we seek to accomplish, then PLEASE meet with us.
We are planning a demonstration at the FDA in front of your building as that is the only alternative left to get your attention. We are sure you will see that news here first….so until next time…..
We know you are watching us. What are you looking for? Better yet, what are you waiting for? 
CareToLive set up this website in June 2007. It was an information site for people protesting the FDA’s poor decision to delay getting Provenge, a safe and effective, non-toxic immunotherapy for men with late stage prostate cancer. These men are dying in excruciating pain and have no other viable treatment option.
Provenge met the criteria for approval as it has proven survival, the gold standard for approval. A panel of FDA hand-picked experts voted Provenge safe, 17-0, and that it demonstrated substantial evidence of efficacy, 13-4.
CareToLive watched as people approached the last FDA Commissioner, Andrew Von Eschenbach, and asked him to reconsider the decision. They gave him some very good reasons. Mr. Von Eschenbach refused. CareToLive incorporated, filed a Citizen’s Petition, and then a lawsuit, and challenged the FDA decision. CareToLive spelled out why Provenge was not given proper due process by the FDA when it processed the Biologic License Application (BLA).
In July 2007 the FDA visited this site. What was it looking for? It was very late at night, around 10:30. Who was at the FDA office and what were they looking for over here? Is that when they gathered to shred and delete documents in response to our lawsuit?
Here is a list for the past seven months when the FDA stopped by this website. 
The FDA stopped by:
09/01/09
10/06/09
10/23/09
10/28/09
11/23/09
12/04/09
12/28/09
12/29/09
12/30/09
01/03/10
01/19/10
01/20/10
01/21/10
02/25/10
03/11/10
03/25/10
The NIH stopped by
12/02/09
Memorial Sloan-Kettering stopped by
12/04/09
12/28/09
Once again, what is the FDA looking for? More important, what is the FDA waiting for? If they read our blogs they saw the latest data presentation from Dendreon, the manufacturer of Provenge. It demonstrates the same safe profile and the survival advantage is better than anything available, by leaps and bounds. What are you waiting for FDA? Approve Provenge NOW!
Popularity: 13%
Tags: cancer, CareToLive, Dendreon, FDA, Howard Scher, Immunotherapy, Josh Sharfstein, Karen Midthun, Kerry M. Donahue, Memorial Sloan Kettering, NCI, NIH, Prostate Cancer, provenge, Richard Pazdur


